|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 22.50 USD | -2.13% |
|
+7.86% | +4.55% |
| 08-07 | Regenxbio Seen on Track for Duchenne Approval as Data Strengthens, RBC Says | MT |
| 08-06 | Sarepta Faces Competitive Pressures Despite Pipeline Updates, RBC Says | MT |
| Market Cap | 2.38B 2.05B 1.92B 1.76B 3.29B 224B 3.3B 22.74B 8.82B 115B 8.92B 8.73B 371B | P/E 2026 * |
7.21x | P/E 2027 * | 40.8x |
|---|---|---|---|---|---|
| Enterprise Value | 2.09B 1.8B 1.69B 1.55B 2.9B 198B 2.9B 20.02B 7.77B 101B 7.86B 7.69B 327B | EV / Sales 2026 * |
1.14x | EV / Sales 2027 * | 1.2x |
| Free-Float |
94.48% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SRPT | Delayed | |
CBOE
| SRPT | Real-time | |
|
Tradegate
| AB3A | Real-time | |
|
Borsa Italiana
| 1SRPT | End-of-day quote | |
|
Börse Stuttgart
| AB3A | Delayed | |
|
Mexican S.E.
| SRPT * | End-of-day quote | |
|
Boerse Muenchen
| AB3A | Real-time | |
|
Deutsche Boerse AG
| AB3A | Delayed | |
|
Berne S.E.
| AB3A | End-of-day quote |
Last Transcript : Sarepta Therapeutics, Inc.
| 1 day | -2.13% | ||
| 1 week | +7.86% | ||
| Current month | +6.99% | ||
| 1 month | +37.28% | ||
| 3 months | +35.05% | ||
| 6 months | +39.84% | ||
| Current year | +4.55% |
| 1 week | 20.18 |  | 23.62 |
| 1 month | 16.35 | | 23.62 |
| Current year | 14.68 | | 24.68 |
| 1 year | 14.68 | | 25.32 |
| 3 years | 10.42 | | 173.25 |
| 5 years | 10.42 | | 173.25 |
| 10 years | 10.42 | | 181.83 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Severino
CEO | Chief Executive Officer | 60 | 2026-07-27 |
Ryan Wong
DFI | Director of Finance/CFO | 47 | 2025-07-15 |
Ian Estepan
DFI | Director of Finance/CFO | 50 | 2020-12-13 |
| Director | Title | Age | Since |
|---|---|---|---|
M. Wilsey
CHM | Chairman | 73 | 2015-04-15 |
| Director/Board Member | 87 | 2010-05-31 | |
Richard Barry
BRD | Director/Board Member | 67 | 2015-06-01 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/28/26 | Free | Chief Executive Officer | 2,980,446 | 2.8230% | ||
| 6/4/26 | Free | Director | 16,875 | 0.0160% | ||
| 6/4/26 | Free | Director | 16,875 | 0.0160% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.13% | +7.86% | +21.89% | -81.63% | 2.38B | |
| +3.03% | -40.26% | -51.09% | -59.50% | 1.5B | |
| -0.21% | -0.21% | -15.07% | -10.63% | 359M | |
| -0.22% | 0.00% | -47.22% | - | 54.15M | |
| Average | +0.12% | -8.16% | -22.87% | -50.59% | 1.07B | |
| Weighted average by Cap. | -0.14% | -9.72% | -7.63% | -67.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.84B 1.58B 1.49B 1.36B 2.54B 173B 2.55B 17.58B 6.82B 89B 6.9B 6.75B 287B | 1.38B 1.19B 1.12B 1.02B 1.91B 130B 1.92B 13.21B 5.13B 66.9B 5.19B 5.07B 216B |
| Net income | 366M 315M 296M 270M 506M 34.53B 507M 3.5B 1.36B 17.71B 1.37B 1.34B 57.07B | 39.41M 33.92M 31.91M 29.15M 54.53M 3.72B 54.68M 377M 146M 1.91B 148M 145M 6.15B |
| Net Debt | -284M -244M -230M -210M -393M -26.81B -394M -2.72B -1.05B -13.76B -1.07B -1.04B -44.31B | -724M -623M -586M -535M -1B -68.33B -1B -6.92B -2.69B -35.06B -2.72B -2.66B -113B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | US$22.50 | -2.13% | 2,955,533 |
| 26-09-03 | US$22.99 | -0.95% | 2,768,345 |
| 26-09-02 | US$23.21 | +8.81% | 4,807,157 |
| 26-09-01 | US$21.33 | +1.43% | 2,623,726 |
| 26-08-31 | US$21.03 | +0.81% | 2,656,894 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SRPT Stock
Select your edition
All financial news and data tailored to specific country editions
